FI952203A0 - Cyklohexanderiat, förfarande för framställning av dessa och användning av föreningar för behandling av sjukdomar - Google Patents

Cyklohexanderiat, förfarande för framställning av dessa och användning av föreningar för behandling av sjukdomar

Info

Publication number
FI952203A0
FI952203A0 FI952203A FI952203A FI952203A0 FI 952203 A0 FI952203 A0 FI 952203A0 FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 952203 A0 FI952203 A0 FI 952203A0
Authority
FI
Finland
Prior art keywords
cyclohexanedrate
diseases
compounds
preparation
treatment
Prior art date
Application number
FI952203A
Other languages
English (en)
Finnish (fi)
Other versions
FI110097B (sv
FI952203A (sv
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-Joerg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI952203A0 publication Critical patent/FI952203A0/sv
Publication of FI952203A publication Critical patent/FI952203A/sv
Application granted granted Critical
Publication of FI110097B publication Critical patent/FI110097B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI952203A 1994-05-10 1995-05-08 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar FI110097B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416433 1994-05-10
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (3)

Publication Number Publication Date
FI952203A0 true FI952203A0 (sv) 1995-05-08
FI952203A FI952203A (sv) 1995-11-11
FI110097B FI110097B (sv) 2002-11-29

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952203A FI110097B (sv) 1994-05-10 1995-05-08 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar

Country Status (23)

Country Link
US (1) US5739147A (sv)
EP (1) EP0682024B1 (sv)
JP (1) JP3790564B2 (sv)
KR (1) KR100355690B1 (sv)
CN (1) CN1043643C (sv)
AT (1) ATE187454T1 (sv)
AU (1) AU683148B2 (sv)
CA (1) CA2149007C (sv)
CZ (1) CZ288443B6 (sv)
DE (2) DE4416433A1 (sv)
DK (1) DK0682024T3 (sv)
ES (1) ES2141276T3 (sv)
FI (1) FI110097B (sv)
GR (1) GR3032519T3 (sv)
HK (1) HK1011989A1 (sv)
HU (1) HU220865B1 (sv)
NO (1) NO304314B1 (sv)
NZ (1) NZ272082A (sv)
PL (1) PL180074B1 (sv)
RU (1) RU2140416C1 (sv)
TW (1) TW421648B (sv)
UA (1) UA41340C2 (sv)
ZA (1) ZA953726B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ES2433476T3 (es) 2000-01-21 2013-12-11 Novartis Ag Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes 5 antidiabéticos
EP1385549A2 (en) * 2001-03-12 2004-02-04 Novartis AG Combination of nateglinide or repaglinide with at least one further antidiabetic compound
PL1931350T5 (pl) 2005-09-14 2021-11-15 Takeda Pharmaceutical Company Limited Podanie inhibitorów dipeptydylo-peptydazy
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
PT2531501E (pt) 2010-02-03 2014-02-17 Takeda Pharmaceutical Inibidores da cinase de regulação do sinal de apoptose 1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (sv) * 1992-09-09 1995-09-01 Hoechst Ag
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
FI110097B (sv) 2002-11-29
PL180074B1 (pl) 2000-12-29
AU683148B2 (en) 1997-10-30
RU2140416C1 (ru) 1999-10-27
HK1011989A1 (en) 1999-07-23
EP0682024A1 (de) 1995-11-15
RU95107147A (ru) 1997-03-20
HUT71797A (en) 1996-02-28
NZ272082A (en) 1996-09-25
HU220865B1 (en) 2002-06-29
ATE187454T1 (de) 1999-12-15
PL308521A1 (en) 1995-11-13
TW421648B (en) 2001-02-11
CZ288443B6 (en) 2001-06-13
CZ119595A3 (en) 1995-12-13
ZA953726B (en) 1996-01-11
CN1118782A (zh) 1996-03-20
NO951820L (no) 1995-11-13
AU1792395A (en) 1995-11-16
FI952203A (sv) 1995-11-11
NO951820D0 (no) 1995-05-09
ES2141276T3 (es) 2000-03-16
NO304314B1 (no) 1998-11-30
CN1043643C (zh) 1999-06-16
DE4416433A1 (de) 1995-11-16
DE59507361D1 (de) 2000-01-13
CA2149007C (en) 2005-07-26
GR3032519T3 (en) 2000-05-31
US5739147A (en) 1998-04-14
KR950032191A (ko) 1995-12-20
EP0682024B1 (de) 1999-12-08
KR100355690B1 (ko) 2002-12-26
UA41340C2 (uk) 2001-09-17
JPH07330767A (ja) 1995-12-19
CA2149007A1 (en) 1995-11-11
DK0682024T3 (da) 2000-05-22
JP3790564B2 (ja) 2006-06-28

Similar Documents

Publication Publication Date Title
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
FI972580A0 (sv) Preparat och förfaranden för minskande av hudirritation
DE69621180D1 (de) 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden
DK0416410T3 (da) Piperaziniocephalosporiner
ATE247114T1 (de) Serotonergische modulatoren
DE3879787D1 (de) 11beta-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE160148T1 (de) Sonnenfilter, diese enthaltende kosmetische lichtschutzzusammensetzungen sowie deren verwendung
ATE118523T1 (de) Flüssigkristall-racematmischung, flüssigkristallzusammensetzung und flüssigkristallelement, verfahren zur herstellung und verwendung.
FI952203A0 (sv) Cyklohexanderiat, förfarande för framställning av dessa och användning av föreningar för behandling av sjukdomar
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
FI955085A (sv) Nya diosmetinföreningar, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa föreningar
ATE179168T1 (de) Substituierte spiroverbindungen zur behandlung von entzündungen
CA2188176A1 (fr) (oxo-1 alkyl) amino-2, deoxy-2 glucopyranoside de dihydroxy - 2,3 propyl, leur procede de preparation et leurs utilisations
DE3688161D1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE69232776D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
FI950681A (sv) Nya akronysinanaloger, förfarande för deras framställning, och farmaceutiska kompositioner, som innehåller dessa föreningar
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE17474T1 (de) Verfahren zur herstellung von cystamin-derivaten mit onkostatischer wirkung.
IT1244649B (it) Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose

Legal Events

Date Code Title Description
MA Patent expired